These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1530786)

  • 21. Effects of human hepatocyte growth factor on the proliferation of human hepatocytes and hepatocellular carcinoma cell lines.
    Efimova EA; Glanemann M; Liu L; Schumacher G; Settmacher U; Jonas S; Langrehr JM; Neuhaus P; Nüssler AK
    Eur Surg Res; 2004; 36(5):300-7. PubMed ID: 15359093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocyte growth factor and plasminogen activation in fulminant hepatic failure.
    Pernambuco JR; Hughes RD; Langley PG; Izumi S; Williams R
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):511-5. PubMed ID: 7841306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of outcome in fulminant hepatic failure by serum human hepatocyte growth factor.
    Tsubouchi H; Kawakami S; Hirono S; Miyazaki H; Kimoto M; Arima T; Sekiyama K; Yoshiba M; Arakaki N; Daikuhara Y
    Lancet; 1992 Aug; 340(8814):307. PubMed ID: 1353217
    [No Abstract]   [Full Text] [Related]  

  • 24. The clinical value of hepatocyte growth factor and its receptor--c-met for liver cancer patients with hepatectomy.
    Wu F; Wu L; Zheng S; Ding W; Teng L; Wang Z; Ma Z; Zhao W
    Dig Liver Dis; 2006 Jul; 38(7):490-7. PubMed ID: 16627020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of HGF-SF in animal and human hepatic physiology and pathology.
    Tsubouchi H; Gohda E; Strain AJ; Daikuhara Y
    EXS; 1993; 65():251-74. PubMed ID: 8422546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum interleukin-6 and hepatocyte growth factor levels in patients after hepatectomy.
    Chijiiwa K; Saiki S; Tanaka M
    Hepatogastroenterology; 2002; 49(44):467-71. PubMed ID: 11995475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levels of hepatocyte growth factor in serum correlate with quality of life in hemodialysis patients.
    Baum E; Pawlaczyk K; Maćkowiak B; Sosinska P; Matecka M; Kolodziejczak B; Musielak M; Breborowicz A
    Int J Clin Exp Pathol; 2015; 8(10):13477-82. PubMed ID: 26722560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic expression of hepatocyte growth factor gene mRNA in acute liver failure.
    Harrison P; Gove C; Bomford A
    Dig Dis Sci; 2000 Oct; 45(10):1913-20. PubMed ID: 11117560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitors of hepatic DNA synthesis in fulminant hepatic failure.
    Hughes RD; Yamada H; Gove CD; Williams R
    Dig Dis Sci; 1991 Jun; 36(6):816-9. PubMed ID: 2032522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo.
    Ishiki Y; Ohnishi H; Muto Y; Matsumoto K; Nakamura T
    Hepatology; 1992 Nov; 16(5):1227-35. PubMed ID: 1427661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic expression of hepatocyte-growth-factor-like/macrophage-stimulating protein mRNA in fulminant hepatic failure.
    Harrison P; Degen SJ; Williams R; Farzaneh F
    Lancet; 1994 Jul; 344(8914):27-9. PubMed ID: 7912298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats.
    Fujiwara K; Nagoshi S; Ohno A; Hirata K; Ohta Y; Mochida S; Tomiya T; Higashio K; Kurokawa K
    Hepatology; 1993 Dec; 18(6):1443-9. PubMed ID: 8244271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transforming growth factor alpha levels in liver and blood correlate better than hepatocyte growth factor with hepatocyte proliferation during liver regeneration.
    Tomiya T; Ogata I; Fujiwara K
    Am J Pathol; 1998 Sep; 153(3):955-61. PubMed ID: 9736044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term effect of hepatocyte transplantation on fulminant hepatic failure in rats.
    Ahmad TA; Fujioka H; Eguchi S; Yanaga K; Kamohara Y; Furui J; Kanematsu T
    Hepatogastroenterology; 2003; 50(50):467-71. PubMed ID: 12749249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum hepatocyte growth factor in acute hepatic failure in comparison with acute hepatitis.
    Shiota G; Okano J; Umeki K; Kawasaki H; Kawamoto T; Nakamura T
    Res Commun Mol Pathol Pharmacol; 1994 Aug; 85(2):157-62. PubMed ID: 7994560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum hepatocyte growth factor levels in hepatectomized and nonhepatectomized surgical patients.
    Tomiya T; Tani M; Yamada S; Hayashi S; Umeda N; Fujiwara K
    Gastroenterology; 1992 Nov; 103(5):1621-4. PubMed ID: 1426882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toxicology and carcinogenesis studies of a binary mixture of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,3',4,4',5-pentachlorobiphenyl (PCB 118) (Cas No. 31508-00-6) in female Harlan Sprague-Dawley rats (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Nov; (531):1-218. PubMed ID: 17342196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in serum levels of growth factors in healthy individuals after living related liver donation.
    Efimova EA; Glanemann M; Nussler AK; Schumacher G; Settmacher U; Jonas S; Nussler N; Neuhaus P
    Transplant Proc; 2005 Mar; 37(2):1074-5. PubMed ID: 15848626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.